Skip to main content
Grifols S.A. logo

Grifols S.A. — Investor Relations & Filings

Ticker · GRF ISIN · ES0171996087 LEI · 959800HSSNXWRKBK4N60 MC Manufacturing
Filings indexed 684 across all filing types
Latest filing 2025-02-25 Regulatory Filings
Country ES Spain
Listing MC GRF

About Grifols S.A.

https://www.grifols.com/en/home

Grifols S.A. is a global healthcare company specializing in the development, production, and marketing of plasma-derived medicines and other biopharmaceutical solutions. As a leading producer of therapies derived from human plasma, the company addresses the needs of patients with chronic, rare, and life-threatening conditions. Its core activities encompass the entire plasma value chain, from collection to the manufacturing of essential protein therapies. In addition to its primary Biopharma division, Grifols provides a comprehensive portfolio of diagnostic solutions for transfusion medicine and clinical laboratories, as well as bio supplies for pharmaceutical and research applications. The company is committed to advancing patient health and well-being through scientific innovation and high standards of quality and safety.

Recent filings

Filing Released Lang Actions
FORM 6-K
Regulatory Filings
2025-02-25 English
Cambios en el Consejo de Administración de Grifols.
Board/Management Information Classification · 99% confidence The document explicitly announces significant changes within the company's governing body (Consejo de Administración). Key events detailed include the resignation intention of the current Chairman (Sr. Thomas Glanzmann), the proposal to reduce the board size, and the naming of his successor (Sra. Anne-Catherine Berner) as the new Non-Executive Chairman. These announcements directly relate to the composition and leadership of the board of directors and senior management. This aligns perfectly with the definition for Board/Management Information (MANG). The document is short and serves as an official communication of these changes, not a full report.
2025-02-25 Spanish
Major Shareholding Notification 2025
Major Shareholding Notification
2025-02-14 English
FORM 6-K
Regulatory Filings
2024-12-23 English
Grifols informa sobre el cierre de una emisión privada de bonos garantizados y la extensión de su línea de crédito revolving.
Capital/Financing Update Classification · 98% confidence The document is a formal communication from Grifols, S.A., titled "OTRA INFORMACIÓN RELEVANTE" (Other Relevant Information), issued under Spanish securities law (Ley 6/2023, artículo 227). The content explicitly details the completion of a bond issuance, the use of proceeds to fully amortize existing Senior Secured Notes, and the settlement of revolving credit facility loans. This content directly relates to changes in the company's financing structure and debt repayment. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP), which covers fundraising, financing activities, or capital structure changes. The document is short and serves as an announcement of a completed financial transaction, not a comprehensive report.
2024-12-23 Spanish
Motivo de la notificación: Persona con Responsabilidad de Dirección
Director's Dealing Classification · 100% confidence The document is titled "MODELO DE NOTIFICACIÓN DE LAS OPERACIONES DE LAS PERSONAS CON RESPONSABILIDADES DE DIRECCIÓN Y DE LAS PERSONAS ESTRECHAMENTE VINCULADAS CON ELLAS" (Standard Form for Notification and Public Disclosure of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with Them). This form explicitly details transactions (Compra/Buy) made by a Director (Consejero Delegado) in the company's shares. This directly corresponds to the definition of Director's Dealing, which covers reports of personal share transactions by company directors and executives (insider trades). The corresponding code is DIRS.
2024-12-16 Spanish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.